We found that TRIM28 expression enhanced immune cell infiltration, especially in BRCA, GBM, LIHC, and PRAD, and that TRIM28 expression levels were positively related to tumor purity (p < 0.001) and the presence of CD4+ T cells (p < 0.001) in BRCA. Here, TRIM28 is linked to neoplasm.